- Home
- LWAY vs ABEO Comparison
LWAY vs ABEO Comparison
Compare LWAY & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LWAY | ABEO |
|---|---|---|
| Founded | 1986 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 368.4M | 320.3M |
| IPO Year | 1995 | 2005 |
Fundamental Metrics
Financial Performance| Metric | LWAY | ABEO |
|---|---|---|
| Price | $31.70 | $6.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $34.50 | $20.00 |
| AVG Volume (30 Days) | 193.8K | ★ 1.5M |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 48.33 | ★ 165.16 |
| EPS | ★ 0.30 | N/A |
| Revenue | ★ $103,350,000.00 | $2,998,000.00 |
| Revenue This Year | $16.64 | $1,024.31 |
| Revenue Next Year | $17.28 | $145.42 |
| P/E Ratio | $103.03 | ★ N/A |
| Revenue Growth | N/A | ★ 258.18 |
| 52 Week Low | $17.31 | $4.00 |
| 52 Week High | $34.20 | $7.54 |
Technical Indicators
Market Signals| Indicator | LWAY | ABEO |
|---|---|---|
| Relative Strength Index (RSI) | 68.37 | 68.05 |
| Support Level | $22.27 | $4.85 |
| Resistance Level | $31.23 | N/A |
| Average True Range (ATR) | 1.79 | 0.32 |
| MACD | 0.17 | 0.12 |
| Stochastic Oscillator | 89.45 | 76.66 |
Price Performance
Historical ComparisonAbout LWAY Lifeway Foods Inc.
Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir, which is a cultured dairy product. Its product categories are Drinkable Kefir, which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir, and Other dairy. The company manufactures and markets products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through a direct sales force, brokers, and distributors.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.